Tyrosinase-oxidoreductase; monophenol, o-diphenol: O2
Porebska-Budny, M.; Dworzański, J.P.
Postepy Biochemii 34(4): 375-394
1988
ISSN/ISBN: 0032-5422 PMID: 3152013 Document Number: 314707
Document emailed within 1 workday
Related Documents
Sarapuu, L.; Heinaru, E. 1971: Oxidation of phlorhizin by o-diphenol oxidase in apple buds Biokhimiia 36(1): 8-17Galindo, J.D.; Martinez, J.H.; Lopez-Ballester, J.A.; Peñafiel, R.; Solano, F.; Lozano, J.A. 1987: The effect of polyamines on tyrosinase activity Biochemistry International 15(6): 1151-1158
Lerch, K. 1988: Protein and active-site structure of tyrosinase Progress in Clinical and Biological Research 256: 85-98
Kwon, B.S.; Haq, A.K.; Kim, G.S.; Pomerantz, S.H.; Halaban, R. 1988: Cloning and characterization of a human tyrosinase cDNA Progress in Clinical and Biological Research 256: 273-282
Cerný, J.; Jandová, A.; Papez, L.; Pezlarová, J. 1977: Determination of L-lactate: NAD+ - oxidoreductase (E.C.1.1.1.27) and its isoenzymes during pregnancy Acta Universitatis Carolinae. Medica. Monographia 1977(78 Part 2): 117-120
Gerasimov, A.M.; Koroleva, L.A.; Ivanova, L.I.; Panchenko, L.F. 1979: Glutathione: dehydroascorbate-oxidoreductase activity in rat tissues Voprosy Meditsinskoi Khimii 25(4): 447-451
Miki, T. 2002: Mitochondrial complex i (NADH-ubiquinone oxidoreductase) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 4): 135-138
Miki, T. 2002: Mitochondrial complex Ii (succinate-ubiquinone oxidoreductase) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 4): 139-143
Agrup, P.; Carstam, R.; Wittbjer, A.; Rorsman, H.; Rosengren, E. 1989: Tyrosinase activity in serum from patients with malignant melanoma Acta Dermato-Venereologica 69(2): 120-124
Jezewska, M. 1990: Divergency of structure and function of vertebrate xanthine:NAD+ oxidoreductase Acta Biochimica Polonica 37(3): 331-344
Errede, B.; Kamen, M.D.; Hatefi, Y. 1978: Preparation and properties of complex IV (ferrocytochrome c: oxygen oxidoreductase EC 1.9.3.1) Methods in Enzymology 53: 40-47
Abdel-Halim, O.B.; Marzouk, A.M.; Mothana, R.; Awadh, N. 2008: A new tyrosinase inhibitor from Crinum yemense as potential treatment for hyperpigmentation Die Pharmazie 63(5): 405-407
Wu, H.; Park, H-Young. 2003: Protein kinase C-beta-mediated complex formation between tyrosinase and TRP-1 Biochemical and Biophysical Research Communications 311(4): 948-953
O'Byrne, S.; Shirodaria, C.; Millar, T.; Stevens, C.; Blake, D.; Benjamin, N. 2000: Inhibition of platelet aggregation with glyceryl trinitrate and xanthine oxidoreductase Journal of Pharmacology and Experimental Therapeutics 292(1): 326-330
Feldheim, W.; Gazo, M. 1971: Xanthine-oxidoreductase (E.C.1.2.3.2.) activity in riboflavin or thiamine deficient rat liver International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 41(2): 221-230
Chen, S.; Deng, P.S.; Swiderek, K.; Li, M.; Chan, S.I. 1995: Interaction of flavones and their bromoacetyl derivatives with NAD(P)H:quinone acceptor oxidoreductase Molecular Pharmacology 47(2): 419-424
Nemeikaite-Ceniene, A.; Dringeliene, A.; Sarlauskas, J.; Cenas, N. 2005: Role of NAD(P)H:quinone oxidoreductase (NQO1) in apoptosis induction by aziridinylbenzoquinones RH1 and MeDZQ Acta Biochimica Polonica 52(4): 937-941
Linder, N.; Rapola, J.; Raivio, K.O. 1999: Cellular expression of xanthine oxidoreductase protein in normal human tissues Laboratory Investigation; a Journal of Technical Methods and Pathology 79(8): 967-974
Sarkar, S.R. 1982: Nad and nadp independent lactate oxidoreductase in schwartz leukemia ascites cells Acta Biologica et Medica Germanica 41(11): 1085-1086
Sugano, H.; Sugano, I.; Jimbow, K.; Fitzpatrick, T.B. 1975: Tyrosinase-mediated inhibition of in vitro leucine incorporation into mouse melanoma by 4-isopropylcatechol Cancer Research 35(11 Part 1): 3126-3130